TrialX
Advanced Filters
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
noise

Found 2,825 clinical trials

S Site User 2 - Vivek

Meal Response, Protein, and PCOS

Polycystic ovary syndrome (PCOS) is a common endocrine disorder characterized by insulin resistance, hyperandrogenism, and reproductive dysfunction. Dietary strategies that improve postprandial insulin and glucose responses are central to managing metabolic symptoms in PCOS. Protein-rich meals can attenuate postprandial glycemia and enhance satiety, but the effects may vary by protein …

18-50 years Female Phase N/A
1 1915 QA

Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne

The purpose of the trial is to evaluate the safety, efficacy and immunogenicity of up to 3 intramuscular injections of the Acne mRNA vaccine candidate at up to three dose levels in adult participants aged 18 to 45 years with moderate to severe acne. This trial will consist of a …

18-45 years All Phase 1/2
a abc

Microlearning-Based Health Education for Ambulatory Surgery Patients

This study is being conducted to explore how microlearning-based health education can improve patients' knowledge, self-confidence in managing their care (self-efficacy), and overall recovery after same-day surgery. Ambulatory surgeries, such as vaginal hysterectomies and mid-urethral sling procedures, are becoming more common because they typically lead to better outcomes and shorter …

18-80 years All Phase N/A
N Nipun B Merchant, MD, FACS

None

All Phase 0
N New_Inv

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RG6496 in Huntington's Disease

This is a first-in-human (FIH) study of RG6496 that will assess the safety and tolerability of single-ascending doses of RG6496 administered to huntington's disease gene expansion carriers (HDGECs). The study consists of two parts: Part 1 [single-ascending dose] followed by Part 2 [open-label extension (OLE)].

25-65 years All Phase 1
F Formal Q1

Effects of a Multimodal Exercise Program on Physical Performance and Muscle Function in Middle-aged Patients With T2DM

Background Middle-aged individuals with T2DM, especially in Asian populations, face a heightened risk of sarcopenia. This condition leads to a decline in muscle mass and function, which negatively impacts their quality of life. Effective interventions are therefore urgently needed to slow the progression of the disease and mitigate these risks.MethodsStudy …

45-64 years All Phase N/A
N Ning-Ning Lu, M.D.

Adaptive Radiotherapy for Genitourinary Cancers

The goal of this clinical trial is to learn if adaptive radiation boost works to treat genitourinary cancers, esp. in the context of prostate cancer patients with post-prostatectomy local relapse and bladder cancer patients with bladder-conserving treatment. It will also learn about the safety and efficacy of adaptive boost. The …

18 years and older Male Phase N/A
f formal-investigator1

New_Trial_001_Site

Test

All
D Divyani Basantani

Divyani - Group-Based Acceptance and Commitment Therapy Versus Active Control in University Students With Emotional Symptoms

This study evaluates the efficacy of a group-based Acceptance and Commitment Therapy (ACT) protocol compared to a non-directive group therapy used as an active control condition in university students presenting moderate to moderate/high levels of emotional symptomatology.Emotional difficulties such as depressive and anxiety symptoms are highly prevalent among university students …

18-28 years All Phase N/A
K Khusboo+investigator@gmail.com

A Study of Chemotherapy Plus Azidothymidine in the Treatment of Kaposi's Sarcoma in Patients With AIDS

To study the safety and maximum tolerated dose (MTD) of combined chemotherapy when it is administered to patients with advanced Kaposi's sarcoma together with one of two different doses of zidovudine (AZT).The combination of AZT and chemotherapy may be effective in treating the tumor as well as preventing the life-threatening …

13 years and older All Phase 1

Simplify language using AI